PROCYTE CORPORATION - Receives European Patent for Hair Growth Expanding Copper Peptide - Patent Portfolio

New York, New York, Mar 05, 2002 (Market News Publishing via COMTEX) --

ProCyte Corporation, a leading skin care and tissue repair company, based on its patented copper peptide technology, announced it has received a new European patent #0765152.

This patent grants new coverage for the stimulation of hair growth using a variety of amino acids, amino acid derivatives, and peptides in combination with copper. It also provides patent coverage for a broad number of therapeutic uses.

The patent is one of a series of patents that have been filed and are in the review process covering new applications and combinations of the GHK and AHK Copper Peptide.

The Company recently licensed its AHK Copper Peptide technology to American Crew for hair care products in the salon and spa markets. They are expected to launch their first products by April 2002 in the U.S. and Europe. Hair loss affects over 60 million people and is a primary concern for many men and women as they age.

The Company continues to conduct scientific research in the area of hair loss with leading medical teams worldwide including researchers at UCSF and University of Florida.

ProCyte Corporation is a healthcare products company that develops and markets products for skin health, hair care and wound care.

The Company's comprehensive therapeutic and anti-aging skin care lines include products for post-procedure treatments and anti-aging applications, as well as products for thinning hair.

Many products incorporate the ProCyte patented, clinically proven Copper Peptide technology, which it markets directly to Dermatologists and plastic surgeons through the Company's own sales force and through distribution partners and licensees for wound care and consumer market segments.

This release may contain forward-looking statements relating to the research, development, commercialization, production, marketing and distribution of the Company's products and future operating results that are subject to certain risks and uncertainties which could cause actual results to differ materially from those projected. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking.

These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. (Factors that could affect the Company's actual results include its ability to develop, commercialize and produce new products, the market acceptance of existing and potential future products, the availability, cost and timely delivery of materials and services from and performance of third party suppliers, manufacturers, distributors, licensees and other collaborative partners, the satisfaction of regulatory requirements, and the receipt, timing, terms and conditions of required regulatory approvals.)

Reference is made to the Company's latest Quarterly Report on Form 10Q or Form 10K filed with the Securities and Exchange Commission for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release.

The Company undertakes no obligation to publicly update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.